Earnings Call · Q2 FY2026·2026-08-12

Q2 26EPS 0.00%·Rev n/aQ1 26EPS -11.76%·Rev n/aQ4 25EPS +40.00%·Rev n/aQ3 25EPS -50.00%·Rev n/a⚠ consensus missing

Longeveron Inc. LGVN

Rachelle — Conference Operator

Derek Cole — Investor Relations, Investor Relations Advisory Solutions

Stephen Willard — Chief Executive Officer

Dr. Nataliya Agafonova — Chief Medical Officer

Marie Washburn — Chief Financial Officer

Dr. Joshua Hare — Co-Founder, Chief Science Officer and Executive Chairman

−6.6%1d on move date3d+9.8%5d+10.0%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LGVN calls or request research access.

More LGVN calls Browse calls Request research access